Nath Bio-Genes (India) Ltd
Nath Bio-Genes: Board Meeting to Consider Q1 FY27 Unaudited Financial Results
RESULTS
● No Immediate Change
LOW RISK
📅 Filed on BSE: 18 Jul 2026, 04:11 PM IST · BSE ID: 7ae67645-f8ac-4e9c-ac12-0509f06df66d
View Original BSE Filing (PDF)
💡
In Simple Terms
Nath Bio-Genes will hold a board meeting on July 29, 2026, to review its financial performance for April-June 2026.
🤖 AI Summary
- Nath Bio-Genes (India) Ltd Board meeting scheduled for Wednesday, July 29, 2026.
- Meeting purpose: to consider and approve Unaudited Financial Results for quarter ended June 30, 2026.
- Financial results will be presented on both standalone and consolidated bases.
- Trading window for company insiders closed on June 30, 2026, reopens August 1, 2026.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this board meeting intimation.
👤
Who Is Affected
All shareholders will be affected by the subsequent financial results once declared, which will provide an update on the company's performance for the quarter ended June 30, 2026.
🔍
Management Signal
The decision to schedule a board meeting for financial results indicates routine compliance with regulatory disclosure requirements for quarterly performance.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Board meeting outcome on July 29, 2026 — declaration of financial results.
Unaudited Financial Results for Q1 FY27 — analyze revenue, profit, and margins.
Trading window reopening on August 1, 2026 — post-results market activity.
LOW RISK
This filing is a procedural notice, presenting no immediate or new risks.
💡 Investor Takeaway
Nath Bio-Genes (India) Ltd's Board will meet on July 29, 2026, to approve Q1 FY27 Unaudited Financial Results for the quarter ended June 30, 2026. The trading window closed June 30, 2026, and reopens August 1, 2026.
❓ Frequently Asked Questions
When is the Board meeting for Nath Bio-Genes (India) Ltd scheduled?
The meeting of the Board of Directors of Nath Bio-Genes (India) Ltd is scheduled for Wednesday, July 29, 2026.
What is the main agenda of the Nath Bio-Genes (India) Ltd Board meeting on July 29, 2026?
The primary agenda of the Board meeting is to consider, approve, and take on record the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026.
When will the trading window for Nath Bio-Genes (India) Ltd re-open?
The trading window for Nath Bio-Genes (India) Ltd will reopen on August 01, 2026, 48 hours after the declaration of the financial results.
Questions based on this BSE filing only. For information purposes.